Literature DB >> 22525602

Adult-derived human liver progenitor cells in long-term culture maintain appropriate gatekeeper mechanisms against transformation.

Isabelle Scheers1, Cedric Maerckx, Dung Ngoc Khuu, Sabrina Marcelle, Anabelle Decottignies, Mustapha Najimi, Etienne Sokal.   

Abstract

The use of human liver progenitor cells in the development of clinical cell therapy depends on their constant availability and unaltered properties during culture. The present study investigates the effects of long-term in vitro culture on the specific characteristics of these cells and on their genetic stability. Adult-derived human liver progenitor cells (ADHLPCs) were isolated from 12 donors and cultured until senescence and cell death. Cells were analyzed at different time points for their phenotype stability and differentiation potential. In addition, growth characteristics, chromosomal karyotype, telomere maintenance mechanisms, and activity of cell cycle-related genes were studied. Finally, their in vivo tumorigenicity was investigated in a xenograft assay. The long-term culture of ADHLPCs revealed a variable proliferation capacity. Cells maintained their original phenotype and acquired hepatocyte-like metabolic functions after differentiation. Eight of the 12 cell populations grew fast (doubling time of 6.3 days) during a limited time period (mean, 116.2 days), and mainly presented normal cytogenetic features. The four other cell cultures presented an early decline in growth potential (doubling time of 28.6 days) and premature senescence. Chromosomal alterations were detected in three of four cultures at passage 6. Cytogenetic anomalies were not correlated with tumorigenic potential in vitro or in vivo, and expression of cell cycle-related genes was appropriately upregulated, inducing senescence. Although chromosomal anomalies may occur in long-term cell cultures, neither transformation nor alteration of their characteristics was noted during in vitro expansion. All ADHLPCs reached senescence and growth arrest. Presenescent ADHLPCs might therefore be considered as a suitable source for liver-based cell therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22525602     DOI: 10.3727/096368912X639026

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  16 in total

Review 1.  Human Liver Progenitor Cells for Liver Repair.

Authors:  Catherine A Lombard; Julie Prigent; Etienne M Sokal
Journal:  Cell Med       Date:  2013-04-29

2.  Hepato-biliary profile of potential candidate liver progenitor cells from healthy rat liver.

Authors:  Cédric Maerckx; Isabelle Scheers; Tatiana Tondreau; David Campard; Omar Nyabi; Mustapha Najimi; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Human liver stem/progenitor cells decrease serum bilirubin in hyperbilirubinemic Gunn rat.

Authors:  Cédric Maerckx; Tatiana Tondreau; Silvia Berardis; Jos van Pelt; Mustapha Najimi; Etienne Sokal
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 4.  Clinical Application of Induced Hepatocyte-like Cells Produced from Mesenchymal Stromal Cells: A Literature Review.

Authors:  Yanina Bogliotti; Mark Vander Roest; Aras N Mattis; Robert G Gish; Gary Peltz; Robin Anwyl; Salah Kivlighn; Eric R Schuur
Journal:  Cells       Date:  2022-06-22       Impact factor: 7.666

Review 5.  Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals.

Authors:  Sathidpak Nantasanti; Alain de Bruin; Jan Rothuizen; Louis C Penning; Baukje A Schotanus
Journal:  Stem Cells Transl Med       Date:  2016-01-21       Impact factor: 6.940

6.  Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency.

Authors:  Etienne M Sokal; Xavier Stéphenne; Chris Ottolenghi; Nawal Jazouli; Philippe Clapuyt; Florence Lacaille; Mustapha Najimi; Pascale de Lonlay; Françoise Smets
Journal:  JIMD Rep       Date:  2013-10-20

7.  Human umbilical cord matrix stem cells maintain multilineage differentiation abilities and do not transform during long-term culture.

Authors:  Isabelle Scheers; Catherine Lombard; Massimiliano Paganelli; David Campard; Mustapha Najimi; Jean-Luc Gala; Anabelle Decottignies; Etienne Sokal
Journal:  PLoS One       Date:  2013-08-09       Impact factor: 3.240

8.  Disease Modeling and Gene Therapy of Copper Storage Disease in Canine Hepatic Organoids.

Authors:  Sathidpak Nantasanti; Bart Spee; Hedwig S Kruitwagen; Chen Chen; Niels Geijsen; Loes A Oosterhoff; Monique E van Wolferen; Nicolas Pelaez; Hille Fieten; Richard W Wubbolts; Guy C Grinwis; Jefferson Chan; Meritxell Huch; Robert R G Vries; Hans Clevers; Alain de Bruin; Jan Rothuizen; Louis C Penning; Baukje A Schotanus
Journal:  Stem Cell Reports       Date:  2015-10-08       Impact factor: 7.765

Review 9.  Treating inborn errors of liver metabolism with stem cells: current clinical development.

Authors:  Etienne Marc Sokal
Journal:  J Inherit Metab Dis       Date:  2014-03-26       Impact factor: 4.982

10.  A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation.

Authors:  Frederik Nevens; Thierry Gustot; Pierre-François Laterre; Luc L Lasser; Lyudmil E Haralampiev; Victor Vargas; Desislava Lyubomirova; Agustin Albillos; Mustapha Najimi; Sébastien Michel; Ivaylo Stoykov; Noelia Gordillo; Yelena Vainilovich; Virginie Barthel; Nathalie Clerget-Chossat; Etienne M Sokal
Journal:  JHEP Rep       Date:  2021-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.